All News

 
PrimeVigilance, an ERGOMED company is awarded 2019 Queen’s Award for Enterprise

Awarded for year-on-year outstanding international trade performance.
Second Queen’s Award for Enterprise following previous award in 2014 in recognition of substantial growth and commercial success

Published
23 April 2019.

Read more
 
PrimeVigilance takes the opportunity to recognise International Women’s Day to say… Thank You!

International Women’s Day #IWD2019 is a global celebration of social, economic, cultural and political achievements of women.

Published
8 March 2019.

Read more
 
News – PrimeVigilance Latest Webinar ‘A Human Touch: Real-World Patient Data in Regulatory Submissions and Beyond’

PrimeVigilance proudly present our latest webinar
‘A Human Touch: Real-World Patient Data in Regulatory Submissions and Beyond’, hosted alongside Pharmafocus and features speakers Dr Forstner, Senior VP and Head of Pharmacoepidemiology and Risk Management and Maartje Smulders, Senior Director Pharmacoepidemiology.

Published
15 February 2019.

Read more
 
News – Dr. Michael Forstner invited to teach at the DIA Europe Annual Meeting in Vienna

PrimeVigilance expert in Benefit-Risk Management, Dr. Michael Forstner PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology invited to teach at the upcoming DIA Europe Annual Meeting in Vienna, taking place on 4-7 February 2019.

Published
18 January 2019.

Read more
 
News – Dr. Michael Forstner & Dr. Jan Petracek selected to speak at DIA Pharmacovigilance & Risk Management Strategies Conference

PrimeVigilance is pleased to announce that both Dr. Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr. Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA PVRMS conference held January 28-30 in Washington, DC.

Published
13 December 2018.

Read more
 
News – Ergomed shortlisted for Best Technological Development in Clinical Trials at SCRIP Awards 2018

London, UK – 28 November 2018: Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, is delighted to have been shortlisted for the Best Technological Development in Clinical Trials category at the 14th Annual SCRIP Awards

Published
28 November 2018.

Read more